Pre-market Most Active: Alcon (ALC.SW, SIX) CHF61.00 14 Feb 2026: earnings watch

ALC.SW stock opened pre-market at CHF61.00 on 14 Feb 2026 as trading activity picked up ahead of Alcon Inc.’s earnings note on 24 Feb 2026. Volume is elevated at 1,248,030.00 shares versus an average of 1,097,905.00, putting Alcon among the most active names on the SIX in Switzerland. Traders are weighing a middling valuation—PE 37.89 and EPS 1.61—against steady cash flow and a surgical and vision-care product mix. We outline why Alcon (ALC.SW) is active, what the numbers say, and where model forecasts place the stock

ALC.SW stock snapshot and market action

Alcon Inc. (ALC.SW) trades on the SIX in Switzerland at CHF61.00 with a day range of CHF59.92–CHF61.44 and a year range of CHF57.68–CHF87.00. Market cap stands at CHF30,170,600,000.00 with 494,600,000.00 shares outstanding. Relative volume is 1.14, signalling above-average interest in pre-market. One clear driver is positioning ahead of the 24 Feb 2026 earnings announcement, which often lifts surgical and vision-care stocks on forward guidance

Why Alcon is among the most active names pre-market

Trading activity reflects three specific catalysts: the upcoming earnings release, steady product sales in cataract and contact lens categories, and technical signs of short-term stabilization. Alcon’s average 50-day price is CHF63.03 and 200-day is CHF65.80, showing the stock sits below both moving averages. Volume spike suggests traders are rotating into or out of positions ahead of guidance and procedure-season updates

Fundamentals, valuation and Meyka AI grade

Alcon posts EPS 1.61 and a PE of 37.89, with revenue per share 20.65 and free cash flow per share 3.22. Meyka AI rates ALC.SW with a score of 74.79 out of 100 (B+, BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Key ratios: price/book 1.77, debt/equity 0.24, and interest coverage 7.25, showing manageable leverage and positive cash conversion metrics

Technicals and trading cues for active traders

Momentum indicators show mixed signals: RSI 58.62 suggests mild strength while MACD is positive (MACD 0.49, signal 0.46). Bollinger band middle sits at CHF63.72; ATR is 1.10, indicating moderate intraday moves. Order-flow traders will note on‑balance volume at 7,207,019.00 and a CCI of 219.70, which can signal short-term overbought pressure. For most-active strategies, watch CHF59.92 pre-market support and CHF61.44 intraday resistance

Earnings, catalysts and sector context

Earnings release set for 24 Feb 2026 is the immediate catalyst. Alcon’s Surgical and Vision Care segments remain sensitive to procedure volumes and contact lens demand. The healthcare sector on the Swiss market shows a year-to-date outperformance of 3.88%, yet Alcon’s 1-year return is -25.54%, highlighting stock-specific weakness versus peers. Monitor procedure trends, product recalls, and pricing commentary in the earnings report

ALC.SW forecast and price-target scenarios

Meyka AI’s forecast model projects a monthly price of CHF59.57, a quarterly price of CHF61.27, and a 12-month price of CHF58.39. Versus the current CHF61.00, that implies a short-term change of +0.44% to the quarterly figure and a 12-month downside of -4.28%. Scenario price targets for traders: short-term target CHF62.50 (+2.46%), base 12-month target CHF58.39 (-4.28%), and a bull target CHF75.00 (+22.95%) if procedure volumes and margin recovery accelerate. Forecasts are model-based projections and not guarantees

Final Thoughts

ALC.SW stock is the most active pre-market on 14 Feb 2026 for clear reasons: elevated volume 1,248,030.00, an imminent earnings date on 24 Feb 2026, and mixed signals from valuation and technicals. Fundamentals show healthy cash flow per share 3.22 and a conservative debt profile (debt/equity 0.24), but the stock trades below its 50- and 200-day averages. Meyka AI rates ALC.SW 74.79/100 (B+, BUY) and the platform’s model projects a quarterly price near CHF61.27 and a 12-month model price CHF58.39 (implied downside -4.28%). Active traders should watch intraday support CHF59.92 and resistance CHF61.44, and treat model targets as probabilistic, not guaranteed. We use Meyka AI as an AI-powered market analysis platform to provide the grade and forecast, but investors should combine these outputs with the upcoming earnings details, sector trends, and personal risk parameters before action

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.